Page 88 - NATIONAL INSTITUTES OF HEALTH (NIH) GUIDELINES FOR CONDUCTING RESEARCH IN MINISTRY OF HEALTH (MOH) INSTITUTIONS & FACILITIES 3RD EDITION 2021
P. 88

IMR INSTITUTIONAL BIOSAFETY & BIOSECURITY COMMITTEE (IMR IBBC)
                                 PRELIMINARY ASSESSMENT FORM

                   INSTITUTE FOR MEDICAL RESEARCH MALAYSIA
                                              Email:  ibbcsecretariat@moh.gov.my

                  *** Please refer to Biosafety Guideline: Risk Assesement of Genetically Modified Organism (Appenddix
                  2)
                  (page 86-95)
                  I  hereby  declare  that  all  information  provided  in  this  application  is  accurate  to  the  best  of  my
                  knowledge.











                    Signature and stamp of Principal Investigator    Date


                  FOR IBBC/IBC OFFICIAL USE ONLY


                       IBBC Ref. No:
                                              Examption Activity
                      Decision by IBBC:
                                         Notification to JBK and Fill up Form E



                     Signature and Stamp
                     of Biosafety Officer /
                      IBBC Secratariat:



                          Date:








                  Note:
                  Please email the complete document to ibbcsecretariat@moh.gov.my within 14 working days from
                  notifiaction date.
                  IMR/IBBC/01
                  Version :  1.0
                  Date  :  20.05.2021                                     Page 2 of 3







          72    NIH Guidelines for Conducting Research in MOH, 2021
   83   84   85   86   87   88   89   90   91   92   93